ADAMTS12 and pancreatic adenocarcinoma: A high level of ADAMTS12 expression was associated with poorer survival rates in patients with pancreatic adenocarcinoma, as well as high levels of tumor-associated macrophages, cancer-associated fibroblasts, immune checkpoint proteins, and immunosuppressive genes, all of which are part of the tumor microenvironment and aid in its progression [53].